Texas House of Representatives · 90th Legislature, Regular Session
Official title: Relating to disclosure and documentation of increased fall risk information for certain prescription drugs prescribed to patients 65 years of age and older.
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)90R
The bill adds Chapter 184 to the Health and Safety Code and requires a licensed physician or health care practitioner who prescribes a "fall risk increasing drug" to a patient 65 or older to tell the patient or the patient's legal guardian about the increased fall risk. The bill defines a fall risk increasing drug as a prescription drug posing a substantial risk to a patient's balance, stability, or alertness. The prescriber must also document in the patient's medical record that this information was given. The disclosure and documentation must follow the form and manner set by the executive commissioner of the Health and Human Services Commission, and must comply with any applicable rules of the state licensing agency that oversees the prescriber. The executive commissioner must develop a list of drugs considered fall risk increasing drugs and post it on the commission's website every year. In building the list, the commissioner may consider drugs identified as raising fall risk in the most current Beers Criteria published by the American Geriatrics Society, or designated by a pharmacy care initiative run by the federal Centers for Disease Control and Prevention. A prescriber who violates the chapter is subject to review and disciplinary action by their licensing agency as if they had violated the agency's own licensing law. The executive commissioner must adopt any needed rules as soon as practicable, and the bill takes effect September 1, 2027.
Read the full text below for the definitive meaning.
Each version links to the authoritative document on capitol.texas.gov.
90R3186 AB-D By: Lalani H.B. No. 550 A BILL TO BE ENTITLED AN ACT relating to disclosure and documentation of increased fall risk information for certain prescription drugs prescribed to patients 65 years of age and older. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subtitle I, Title 2, Health and Safety Code, is amended by adding Chapter 184 to read as follows:
CHAPTER 184. DISCLOSURE AND DOCUMENTATION OF INCREASED FALL RISK INFORMATION FOR CERTAIN PRESCRIPTION DRUGS Sec. 184.001. DEFINITION. In this chapter, "fall risk increasing drug" means a prescription drug posing a substantial risk to a patient's balance, stability, or alertness. Sec. 184.002. REQUIRED DISCLOSURE AND DOCUMENTATION. (a) Each physician and health care practitioner licensed to practice in this state who prescribes a fall risk increasing drug to a patient who is 65 years of age or older shall disclose to the patient or the patient's legal guardian information on the increased fall risk associated with use of the drug. (b) A physician or health care practitioner who prescribes a fall risk increasing drug to a patient 65 years of age or older shall document in the patient's medical record that the physician or practitioner provided to the patient the information required by Subsection (a). (c) The disclosure and documentation required under this section must be in the form and manner prescribed by the executive commissioner and comply with any applicable rules adopted by the state licensing agency with regulatory authority over the physician or health care practitioner. Sec. 184.003. LIST OF FALL RISK INCREASING DRUGS. (a) The executive commissioner shall develop a list of prescription drugs considered to be a fall risk increasing drug and shall annually post the list on the commission's Internet website. (b) In developing the list required under Subsection (a), the executive commissioner may consider for inclusion on the list prescription drugs: (1) identified as increasing the risk of falls under the most current edition of the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults published by the American Geriatrics Society; or (2) designated as a fall risk increasing drug by a pharmacy care initiative administered by the federal Centers for Disease Control and Prevention. Sec. 184.004. DISCIPLINARY ACTION. A physician or health care practitioner who holds a license issued by a state licensing agency is subject to review and disciplinary action by the agency for a violation of this chapter as if the physician or practitioner violated the applicable licensing law. SECTION 2. As soon as practicable after the effective date of this Act, the executive commissioner of the Health and Human Services Commission shall adopt any rules necessary to implement Chapter 184, Health and Safety Code, as added by this Act. SECTION 3. This Act takes effect September 1, 2027.
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
SourceU.S. Census Bureau (ACS) & CDC PLACESstatewide Data layer
Each subject links to other 90R bills tagged the same way.
SourceTexas Legislative Council (capitol.texas.gov)90R
No recorded roll-call votes on this bill.
SourceLegiScan (CC BY 4.0)90R
No fiscal notes or analyses recorded for this bill.
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)
SourceLegiScan (CC BY 4.0)subject tags